U.S. House panel questions FDA's track record combating illegal opioids


By Sarah N. Lynch WASHINGTON (Reuters) – U.S. lawmakers worry the Food and Drug Administration isn’t doing sufficient to prevent the glide of illegal medication into the United States as the rustic works to struggle the opioid epidemic. Republican and Democratic individuals at the House Energy and Commerce Committee wondered whether or not the FDA’s legal investigators are efficient at blocking off illegal medication at U.S. ports of access, in a letter observed through Reuters. “We have issues about whether or not the FDA is as it should be devoting its sources to prioritize those efforts in opposition to unapproved opioids,” wrote the lawmakers, together with the panel’s Republican Chairman Greg Walden and main Democrat Frank Pallone, in a letter to FDA Commissioner Scott Gottlieb.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *